Pharma Marketletter - Requip shows use for restless legs syndrome.
The results of two studies showing the potential utility of GlaxoSmithKline’s Requip (ropinirole) in the treatment of restless legs syndrome were presented at the Associated Professional Sleep Societies’ annual meeting in Chicago, USA. There are currently no medicines approved by the Food and Drug Administration for this indication. …
Most Popular
Public Speaking: 7 Secrets Of Great Public Speakers
5 Regular Mistakes In Public Speaking
10 Jobs That Pay $30 An Hour
Job Hunt Backlash…How The Tough Questions Can Strangle You!
3 Questions No Job Seeker Ever Wants To Be Asked?
Want to read the whole article? You can purchase it here. It’s quick and easy.
